Traditional medicinal chemistry paradigms, relying initially on ‘wet’ chemistry followed by screening and lead optimizations, are expensive and time consuming. On the other hand, initial in silico screening that guides the synthesis and screening of selected compounds has proven to be a better approach to accelerate drug discovery and reduce the cost of the discovery phase. The Special Focus is...